@ScottWaudbyHaemResLeics (@HaemResLeic) header
@ScottWaudbyHaemResLeics (@HaemResLeic) profile picture

The Ernest and Helen Scott Haematological Research Institute

University of Leicester
Joined June 2020
Research on blood cancer happens @uniofleicester
2
@ScottWaudbyHaemResLeics retweeted
Pleased to share some new PhD opportunities advertised within LCRC @uniofleicester to start this year including one within our institute le.ac.uk/study/research-degr… @HaemResLeic
5
5
380
Harriet Walter (Leicester ECMC) is a co-author on a Phase I/II study looking at EZH2/EZH1 inhibitor in solid tumours or hematologic malignancies & reporting preliminary Phase II results at #ASCO23. Check out abstract #3094, poster #292 at 8 AM – bit.ly/3WEeh7k
2
7
945
@ScottWaudbyHaemResLeics retweeted
Great day for @HaemResLeic with @isogenicaltd and other university colleagues yesterday supported by @IPH_UK @uniofleicester @uolcollegecourt working on existing funding awards @UKRI_News @Impact_Aim_Mrc and building new collaborations.
1
3
192
Congratulations to the @uniofleicester who have successfully renewed their bid to host an #NIHR-#CRUK Experimental Cancer Medicine Centre. The #ECMC works alongside our Hope Cancer Trials Centre @Leic_hospital to develop and deliver the latest cancer treatments for patients.
1
3
20
1,933
@ScottWaudbyHaemResLeics retweeted
Thank you Dr Matt Ahearne for taking the time to talk to us 💙 Hope Against Cancer works in partnership with local universities and hospitals to make sure that Leicestershire is a hub of expertise in cancer research and treatment. hopeagainstcancer.org.uk/
3
8
Looking for a PhD on blood cancer? Wonder how T cells fitness could predict response to immunotherapy? We have an exciting MRC AIM iCase PhD project using a multi-omics approach more.bham.ac.uk/mrc-aim/phd-… application deadline: 9th January 2022.
We have an exciting opportunity for a MSc or PhD to join us as a Research Assistant to evaluate a novel therapeutic agent in blood cancer jobs.le.ac.uk/vacancies/3881…
@ScottWaudbyHaemResLeics retweeted
A new, chemotherapy-free treatment for chronic lymphocytic leukaemia (CLL) is to be available on the NHS, it has been announced. https://teapawt.org/t.co/rgi8AXJ38k
@ScottWaudbyHaemResLeics retweeted
📰 IN THE NEWS: Researchers from the Leicester Cancer Research Centre have helped develop a genetic test to predict a common type of leukaemia (via @leicslive). Read more 👇 leicestermercury.co.uk/news/… #CitizensofChange
4
11
@ScottWaudbyHaemResLeics retweeted
Following the Hope Cancer Trials Centre's expansion, here is what Professor Anne Thomas, the clinical lead for the centre, has to say ⬇️ Thank you everyone who has supported us and contributed to our cause 💙 #charity #fundraising #donate #nonprofit #support
1
3
5
Breaking News: we have an exciting translational iCase PhD project available @HaemResLeic @uniofleicester to work in collaboration with @isogenicaltd to develop and assess novel therapeutic antibodies for treatment of lymphoma. @ImpactMrc more.bham.ac.uk/mrc-impact/p…
3
4
@ScottWaudbyHaemResLeics retweeted
Do join @DrChrisPFox, @MJAhearne, Prof Tim Illidge & myself at what should be a fascinating symposium on T-cell lymphoma. New @BritSocHaem guidelines on PTCL soon, so v timely. 3 scintillating talks & hopefully a lively Q&A. So get the coffee on and join us 8am, 12th November!
4
2
19
@ScottWaudbyHaemResLeics retweeted
And here it is 😁 👇 teapawt.org/bloodcancer_uk/status/…
To kick-start #BloodCancerAwarenessMonth we challenged our chief executive @GemmaPeters to channel @JacindaArdern and speed through 60 years of beating blood cancer in *TWO MINUTES*! Does she manage it?? Watch now ⏱️👀👇
3
4
Vikki's paper is out in Haematologica's August issue. A massive piece of work looking at the dependency of different BCL-2 family proteins for survival in DLBCL and their potential use as therapeutic targets. Congratulations to all authors! @viklarr @MartinJSDyer Meike Vogler
In #DLBCL, the heterogeneous response to #BH3-mimetics is mediated by selective interactions between BAX, BAK and anti-apoptotic #BCL-2 proteins. buff.ly/31frJSZ
Coming from around UK, from around the World but all @HaemResLeic so proud to work @uniofleicester and to live in this vibrant city #TogetherInHope #WeAreLeicester
3
@ScottWaudbyHaemResLeics retweeted
Leicester is an incredible city. There is so much diversity and unity in one place. It’s more important now than ever to come together and shine a light on what is great about our city. Let us shape our future together. #TogetherInHope #WeAreLeicester
15
144
8
407
This study confirms the promising efficacy of tirabrutinib both as monotherapy or in combination with other BCR signaling pathway inhibitors. 6 patients treated @Leic_hospital at the Hope Clinical Trial Facility @MartinJSDyer @HarrietSWalter @hopeagnstcancer
Results of the Phase Ib Study using Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia are now published. clincancerres.aacrjournals.o…
1
3
Results of the Phase Ib Study using Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia are now published. clincancerres.aacrjournals.o…
@ScottWaudbyHaemResLeics retweeted
Herein, the Authors review the current understanding of #CD20function, and the mechanisms of its regulation in normal and malignant #Bcells, highlighting the therapeutic implications. buff.ly/3h5UnNr
1
32
1
65